https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-13 / J Neurooncol 2021 May;152(3):419-428
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-13 / J Neurooncol 2021 May;152(3):419-4282021-03-13 00:00:002021-03-13 00:00:00Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)2021-03-12 00:00:002021-03-12 00:00:00Hyperthermia-Based Anti-Cancer Treatments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-10 / Int J Mol Sci 2021 Mar;22(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-10 / Int J Mol Sci 2021 Mar;22(6)2021-03-10 00:00:002021-03-10 00:00:00Cell Therapies in Bladder Cancer Management
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-07 / Biomolecules 2021 Mar;11(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-07 / Biomolecules 2021 Mar;11(3)2021-03-07 00:00:002021-03-07 00:00:00Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-01 / Gan To Kagaku Ryoho 2021 Mar;48(3):388-390
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-01 / Gan To Kagaku Ryoho 2021 Mar;48(3):388-3902021-03-01 00:00:002021-03-01 00:00:00Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-27 / Ann Surg Oncol 2021 Oct;28(11):6126-6137
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-27 / Ann Surg Oncol 2021 Oct;28(11):6126-61372021-02-27 00:00:002021-02-27 00:00:00A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-6139
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-61392021-02-26 00:00:002021-02-26 00:00:00ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-25 / Neuro Oncol 2021 02;23(2):240-250
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-25 / Neuro Oncol 2021 02;23(2):240-2502021-02-25 00:00:002021-11-15 19:08:36DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-25 / Front Oncol 2021;11:590764
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-25 / Front Oncol 2021;11:5907642021-02-25 00:00:002021-02-25 00:00:00Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-12 / Oncol Lett 2021 Apr;21(4):286
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-12 / Oncol Lett 2021 Apr;21(4):2862021-02-12 00:00:002021-02-12 00:00:00Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues
